Histotripsy Archives

Tag: Histotripsy

Histotripsy is a noninvasively focused ultrasound wave used to mechanically destroy target tissue with millimeter precision. The relatively new technique is currently being used in a human liver cancer trial in the United States and Europe.

In many clinical situations, the entirety of a cancerous tumor cannot be targeted directly in treatments for reasons that include the mass’ size, location or stage. To investigate the effects of partially destroying tumors with sound, this latest study targeted only a portion of each mass, leaving behind a viable intact tumor. It also allowed the team, including researchers at Michigan Medicine and the Ann Arbor VA Hospital, to show the approach’s effectiveness under less than optimal conditions.

Histotripsy is a promising option that can overcome the limitations of currently available ablation modalities and provide safe and effective noninvasive liver tumor ablation.

13 Mar 2025

By Ronny Allan

4 Comments

Histotripsy – the case for use in UK as Histosonics was awarded early market access

Clinical Trials and Research, Patient Advocacy, TreatmentAblation, Advanced neuroendocrine cancer, Histotripsy, Liver directed therapy

Hot off the press - 10 Mar 2026 Wellington Hospital London is now the first independent hospital in Europe to offer Histotripsy. Clearly treatment at this hospital will need to be funded by the individual or covered by a private healthcare insurance policy.Click here to read more. Hot off the press - 22 Oct 2025 Cambridge treats first NHS cancer patient A Cambridge patient has become the first person in Europe to receive cutting-edge histotripsy treatment outside of a clinical trial, after the technology was fast-tracked by the Government - marking a major milestone in NHS cancer care. Addenbrooke’s is…

14 Oct 2023

By Ronny Allan

5 Comments

Meet Edison® Histotripsy System – powerful bubbles

Clinical Trials and Research, Patient Advocacy, TreatmentAblation, Histotripsy, Liver directed therapy, Liver metastases

Please read this before asking questions Histotripsy is a new treatment, but it's an ablative technique rather than a drug. It can be equated to liver embolization or conventional tumour ablation but uses what would appear to be a more effective targeted therapy. It's early days, the fact that it has been approved by FDA (see wording below) is about all we know but this blog will be kept live. I get asked a lot of questions but some of the detail NET patients tend to ask is simply not available to me. 1. Where can I get this treatment? …

14 Jan 2023

By Ronny Allan

0 Comments

Cancer Ablation

Clinical Trials and Research, Patient Advocacy, TreatmentAblation, High-intensity focused ultrasound (HIFU), Histotripsy, Radio Frequency Ablation (RFA), Stereotactic body radiotherapy (SBRT), Stereotactic radiosurgery (SRS)

What is Cancer Ablation? This is a minimally invasive surgical method to treat solid cancers. More modern types of ablative style treatments may be described as non-invasive. With conventional ablation, special probes are used to “burn” or “freeze” cancers. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumour. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer. “Burning” refers to…

25 Apr 2022

By Ronny Allan

2 Comments

Histotripsy: A new technique that treats cancer using soundwaves

Clinical Trials and Research, TreatmentAblation, High-intensity focused ultrasound (HIFU), Histotripsy, Liver metastases

First published on April 25, 2022. Updated regularly. Last update 2nd Aug 2026. If you just want to know what Histotripsy is, just head straight down to "Original Article" section 2nd August 2026. Hong Kong - Pancreatic Cancer A pioneering medical team in Hong Kong has successfully completed the first two clinical trial cases using histotripsy to treat pancreatic cancer, offering new hope for patients with one of the most challenging forms of the disease. This marks a significant leap forward in adopting the non-invasive technology in Asia. Click here. 1st August 2026. Hong Kong Training Centre On 8th July…